Moreover, somatic mutations of NRF2 and its regulator Kelch-like ECH-associated protein 1 (KEAP1) have been reported to be highly correlated with poor prognosis in type II pRCC and pancreatic cancer [82,84,85]. Here, KEAP1 is linked to pancreatic neoplasm.